您的位置: 首页 > 农业专利 > 详情页

Ocular gene therapy using avalanche-mediated transfection
专利权人:
Thomas W. Chalberg; Jr.
发明人:
Thomas W. Chalberg, Jr.,Mark Blumenkranz,Daniel V. Palanker,Alexander Vankov,Philip Huie, Jr.,Michael F. Marmor,Michele P. Calos
申请号:
US11505249
公开号:
US08101169B2
申请日:
2006.08.15
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention provides a method of treating an ocular disease in a subject. In a first step, a nucleic acid is introduced into cells or a tissue. The nucleic acid is introduced by electron avalanche transfection. With this technique, a high electric field induces a vapor bubble and plasma discharge between an electrode and the surrounding medium. The formation of a vapor bubble generates mechanical stress. Plasma discharge through the ionized vapor in the bubble enables connectivity between the electrode and the surrounding medium, so that mechanical stress and electric field are applied simultaneously, which results in permeabilization of the cells or tissue. This permeabilization in turn allows the nucleic acid to enter the cell or tissue. Cells or tissue containing the nucleic acid are then transplanted into an ocular region of the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充